{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:21:08Z","timestamp":1782184868629,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272488"],"award-info":[{"award-number":["81272488"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602802"],"award-info":[{"award-number":["81602802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jpha.2023.04.017","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:50:12Z","timestamp":1682650212000},"page":"603-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically"],"prefix":"10.1016","volume":"13","author":[{"given":"Liuyun","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinliang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongze","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2023.04.017_bib1","first-page":"273","article-title":"Disparities in liver cancer occurrence in the United States by race\/ethnicity and state","volume":"67","author":"Islami","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jpha.2023.04.017_bib2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41575-021-00465-x","article-title":"Exploring liver cancer biology through functional genetic screens","volume":"18","author":"Wang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpha.2023.04.017_bib3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jhep.2018.07.004","article-title":"Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer","volume":"69","author":"Wang","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jpha.2023.04.017_bib4","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-17-0483","article-title":"Combination therapy with NHS-muIL12 and avelumab (anti-PD-L1) enhances antitumor efficacy in preclinical cancer models","volume":"23","author":"Xu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2023.04.017_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41418-021-00869-x","article-title":"Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers","volume":"29","author":"Montinaro","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jpha.2023.04.017_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.126080","article-title":"De novo supraparticle construction by a self-assembled Janus cyclopeptide to tame hydrophilic microRNA and hydrophobic molecule for anti-tumor cocktail therapy and augmented immunity","volume":"401","author":"She","year":"2020","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jpha.2023.04.017_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2015.10.022","article-title":"Recent advances of cocktail chemotherapy by combination drug delivery systems","volume":"98","author":"Hu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpha.2023.04.017_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.annonc.2021.11.018","article-title":"Veliparib monotherapy following carboplatin\/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: Results of exploratory analyses from the phase III BROCADE3 trial","volume":"33","author":"Han","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jpha.2023.04.017_bib9","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41596-022-00698-3","article-title":"Formulation of two lipid-based membrane-core nanoparticles for FOLFOX combination therapy","volume":"17","author":"Guo","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jpha.2023.04.017_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.annonc.2021.11.002","article-title":"First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer","volume":"33","author":"Niu","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jpha.2023.04.017_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/SLA.0000000000004143","article-title":"A combination of biochemical and pathological parameters improves prediction of postresection survival after preoperative chemotherapy in pancreatic cancer: The PANAMA-score","volume":"275","author":"Hank","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.jpha.2023.04.017_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.780724","article-title":"Nuclear exportin 1 (XPO1) binds to the nuclear localization\/export signal of the turnip mosaic virus NIb to promote viral infection","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jpha.2023.04.017_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature19771","article-title":"XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer","volume":"538","author":"Kim","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2023.04.017_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.tig.2012.01.003","article-title":"Evolution of the cancer genome","volume":"28","author":"Podlaha","year":"2012","journal-title":"Trends Genet."},{"key":"10.1016\/j.jpha.2023.04.017_bib15","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nm.3392","article-title":"Tumor adaptation and resistance to RAF inhibitors","volume":"19","author":"Lito","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpha.2023.04.017_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.gastro.2021.03.022","article-title":"Sequential administration of XPO1 and ATR inhibitors enhances therapeutic response in TP53-mutated colorectal cancer","volume":"161","author":"Inoue","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jpha.2023.04.017_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.09.003","article-title":"Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition","volume":"71","author":"Haynes","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jpha.2023.04.017_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2018.06.010","article-title":"The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma","volume":"432","author":"Shi","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jpha.2023.04.017_bib19","doi-asserted-by":"crossref","first-page":"11664","DOI":"10.1021\/acsnano.8b07079","article-title":"Turning a Luffa protein into a self-assembled biodegradable nanoplatform for multitargeted cancer therapy","volume":"12","author":"He","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpha.2023.04.017_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201807736","article-title":"Self-assembly of therapeutic peptide into stimuli-responsive clustered nanohybrids for cancer-targeted therapy","volume":"29","author":"He","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jpha.2023.04.017_bib21","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1021\/acs.nanolett.9b03028","article-title":"A hierarchical peptide-lanthanide framework to accurately redress intracellular carcinogenic protein-protein interaction","volume":"19","author":"Yan","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jpha.2023.04.017_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jare.2022.05.009","article-title":"Turning chiral peptides into a racemic supraparticle to induce the self-degradation of MDM2","volume":"45","author":"Yang","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jpha.2023.04.017_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2020.06.041","article-title":"Resurrecting a p53 peptide activator - An enabling nanoengineering strategy for peptide therapeutics","volume":"325","author":"He","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2023.04.017_bib24","doi-asserted-by":"crossref","first-page":"8513","DOI":"10.7150\/thno.47243","article-title":"A general-purpose nanohybrid fabricated by polymeric Au(I)-peptide precursor to wake the function of peptide therapeutics","volume":"10","author":"Yan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jpha.2023.04.017_bib25","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.7150\/thno.27165","article-title":"Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery","volume":"8","author":"Bian","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jpha.2023.04.017_bib26","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.7150\/thno.70568","article-title":"Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapy","volume":"12","author":"He","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jpha.2023.04.017_bib27","article-title":"Turing miRNA into infinite coordination supermolecule: A general and enabling nanoengineering strategy for resurrecting nuclear acid therapeutics","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.jpha.2023.04.017_bib28","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.7150\/thno.59020","article-title":"A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity","volume":"11","author":"Yan","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jpha.2023.04.017_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2019.03.026","article-title":"A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties","volume":"206","author":"He","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jpha.2023.04.017_bib30","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1021\/acs.nanolett.0c01757","article-title":"Chiral protein supraparticles for tumor suppression and synergistic immunotherapy: An enabling strategy for bioactive supramolecular chirality construction","volume":"20","author":"Yan","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jpha.2023.04.017_bib31","article-title":"Deep tumor penetrating gold nano-adjuvant for NIR-II-triggered in situ tumor vaccination","volume":"18","author":"Chen","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jpha.2023.04.017_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202107656","article-title":"All-in-one biomimetic nanoplatform based on hollow polydopamine nanoparticles for synergistically enhanced radiotherapy of colon cancer","volume":"18","author":"Gong","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jpha.2023.04.017_bib33","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1080\/21655979.2021.1931642","article-title":"Identification of significant genes and therapeutic agents for breast cancer by integrated genomics","volume":"12","author":"Sun","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.jpha.2023.04.017_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-014-0085-1","article-title":"Nucleo-cytoplasmic transport as a therapeutic target of cancer","volume":"7","author":"Gravina","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jpha.2023.04.017_bib35","article-title":"One stone, two birds: A peptide-Au(I) infinite coordination supermolecule for the confederate physical and biological radiosensitization in cancer radiation therapy","volume":"19","author":"Wang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jpha.2023.04.017_bib36","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1021\/acs.nanolett.1c02899","article-title":"Alkyl-terminated gold nanoparticles as a self-therapeutic treatment for psoriasis","volume":"21","author":"Han","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jpha.2023.04.017_bib37","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/nl300027p","article-title":"Surface-engineered gold nanorods: Promising DNA vaccine adjuvant for HIV-1 treatment","volume":"12","author":"Xu","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.jpha.2023.04.017_bib38","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1021\/acsnano.6b05113","article-title":"Gold-nanoclustered hyaluronan nano-assemblies for photothermally maneuvered photodynamic tumor ablation","volume":"10","author":"Han","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpha.2023.04.017_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22050857","article-title":"Applications of gold nanoparticles in nanomedicine: Recent advances in vaccines","volume":"22","author":"Carabineiro","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jpha.2023.04.017_bib40","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/biom10101429","article-title":"Role of glutathione in cancer: From mechanisms to therapies","volume":"10","author":"Kennedy","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpha.2023.04.017_bib41","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/ac2024188","article-title":"Real-time monitoring of glutathione-triggered thiopurine anticancer drug release in live cells investigated by surface-enhanced Raman scattering","volume":"84","author":"Ock","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpha.2023.04.017_bib42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/acs.accounts.1c00635","article-title":"Rational design of nanotherapeutics based on the five features principle for potent elimination of cancer stem cells","volume":"55","author":"Zhang","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jpha.2023.04.017_bib43","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1021\/acsnano.7b01744","article-title":"Gold nanoparticles induced endothelial leakiness depends on particle size and endothelial cell origin","volume":"11","author":"Setyawati","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpha.2023.04.017_bib44","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1080\/10717544.2017.1377316","article-title":"Dual targeting of L-carnitine-conjugated nanoparticles to OCTN2 and ATB0,+ to deliver chemotherapeutic agents for colon cancer therapy","volume":"24","author":"Kou","year":"2017","journal-title":"Drug Delivery"},{"key":"10.1016\/j.jpha.2023.04.017_bib45","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1166\/jbn.2018.2633","article-title":"Co-delivery of triptolide and curcumin for ovarian cancer targeting therapy via mPEG-DPPE\/CaP nanoparticle","volume":"14","author":"Liu","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jpha.2023.04.017_bib46","first-page":"1469","article-title":"SPOP regulates the DNA damage response and lung adenocarcinoma cell response to radiation","volume":"9","author":"Dong","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jpha.2023.04.017_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/15384101.2019.1706903","article-title":"The double dealing of cyclin D1","volume":"19","author":"Tchakarska","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jpha.2023.04.017_bib48","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2217\/nnm-2019-0140","article-title":"Biocompatibility in regenerative nanomedicine","volume":"14","author":"Zor","year":"2019","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.jpha.2023.04.017_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/jcim-2020-0327","article-title":"Acute and subacute toxicity assessment of Madhulai Manappagu (Siddha herbal syrup formulation) in animal model","volume":"19","author":"Malayappan","year":"2021","journal-title":"J. Complement. Integr. Med."},{"key":"10.1016\/j.jpha.2023.04.017_bib50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/met.2019.0038","article-title":"The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance, and blood lipid panels in individuals with nonalcoholic fatty liver disease","volume":"17","author":"Parker","year":"2019","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.jpha.2023.04.017_bib51","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1002\/cam4.3086","article-title":"AST\/ALT ratio as a significant predictor of the incidence risk of prostate cancer","volume":"9","author":"Zhou","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.jpha.2023.04.017_bib52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7754\/Clin.Lab.2016.160536","article-title":"Method comparison and bias estimation of blood urea nitrogen (BUN), creatinine (Cr), and uric acid (UA) measurements between two analytical methods","volume":"63","author":"Cai","year":"2017","journal-title":"Clin. Lab."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177923000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177923000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:35:21Z","timestamp":1761860121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177923000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2095177923000849"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2023.04.017","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2023.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}]}}